BIOMAT Database Logo BIOMAT Database Logo

Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. 1987

P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner

UI MeSH Term Description Entries
D008636 Mesencephalon The middle of the three primitive cerebral vesicles of the embryonic brain. Without further subdivision, midbrain develops into a short, constricted portion connecting the PONS and the DIENCEPHALON. Midbrain contains two major parts, the dorsal TECTUM MESENCEPHALI and the ventral TEGMENTUM MESENCEPHALI, housing components of auditory, visual, and other sensorimoter systems. Midbrain,Mesencephalons,Midbrains
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
January 1991, Acta neurochirurgica. Supplementum,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Intracerebral grafting and culture of cryopreserved primate dopamine neurons.
December 1987, Brain research,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Transplantation strategies in the treatment of Parkinson's disease: experimental basis and clinical trials.
January 1989, Acta neurologica Scandinavica. Supplementum,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Brain grafting for Parkinson's disease. Experimental, clinical, and immunological considerations.
March 1991, Transplantation,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease.
September 2021, Neuronal signaling,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.
October 2011, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
January 2010, Movement disorders : official journal of the Movement Disorder Society,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
March 2001, The New England journal of medicine,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
July 2001, The New England journal of medicine,
P Brundin, and R E Strecker, and O Lindvall, and O Isacson, and O G Nilsson, and G Barbin, and A Prochiantz, and C Forni, and A Nieoullon, and H Widner
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
July 2001, The New England journal of medicine,
Copied contents to your clipboard!